Clinical trial Recruiting at 1 site Observational Ages 18 to 85

DeepComp: AI prediction of complications after stomach cancer surgery

Official title: A Prospective, Multicenter, Observational Study Validating the Multimodal Deep Learning Radiomics Model (DeepComp) for Preoperative Prediction of Major Postoperative Complications in Patients With Gastric Cancer

Run by Hebei Medical University · NCT07401173 · Data updated 2026-11-12

This project will try an AI tool called DeepComp to predict which adults with gastric adenocarcinoma scheduled for curative stomach surgery are at high risk of moderate-to-severe postoperative complications using routine preoperative CT scans and clinical data.

More Postoperative Complications trials

Quick facts

Study typeObservational
Ages18 Years to 85 Years
SexAll
Enrollment500 (estimated)
SponsorHebei Medical University
Academic / other
Locations1 site (Shijiazhuang, None Selected)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedMay 1, 2026
Study endsMay 1, 2026
Registry record updatedApril 9, 2026
Trial IDNCT07401173 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with histologically confirmed gastric adenocarcinoma who are scheduled for elective curative radical gastrectomy and have a standard contrast-enhanced abdominal CT within 14 days before surgery and can provide informed consent.

Probably not a fit

Patients undergoing emergency surgery, those found to have unresectable or metastatic disease intraoperatively, recent other malignancies, pregnant or lactating patients, or those with CT scans rendered unreadable by severe metallic artifacts are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, multicenter observational study will enroll adults with histologically confirmed gastric adenocarcinoma who are scheduled for elective radical gastrectomy. Researchers will collect routine preoperative contrast-enhanced abdominal CT scans (venous phase) performed within 14 days before surgery plus standard clinical data, then extract radiomic features and body-composition measures (muscle and fat distribution). The DeepComp AI model will integrate these imaging-derived features with clinical variables to generate preoperative risk predictions for moderate-to-severe postoperative complications. Predicted risks will be compared with actual postoperative outcomes to validate the model's performance across participating centers.

Why it matters

Potential benefit: If successful, DeepComp could help doctors identify patients at higher risk before surgery so perioperative care can be personalized to reduce complications and improve recovery.

How similar studies have gone: Retrospective studies combining radiomics and body-composition metrics have shown promising results for predicting surgical risk, but prospective multicenter validation like this is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Age ≥ 18 years.

Histologically confirmed gastric adenocarcinoma.

Scheduled for elective radical gastrectomy (open, laparoscopic, or robotic) with curative intent.

Standard preoperative contrast-enhanced abdominal CT scans (venous phase) performed within 14 days prior to surgery.

Willingness to sign informed consent.

Exclusion Criteria:

Emergency surgery due to perforation, obstruction, or massive bleeding.

Intraoperative findings of distant metastasis (Stage IV) or unresectable disease preventing R0 resection.

Concurrent or previous malignant tumors within the last 5 years (except gastric cancer).

Pregnancy or lactation.

Severe metallic artifacts on CT images preventing radiomic analysis.

Where it's running

  • the Fourth Hospital of Hebei Medical University
    Shijiazhuang, None Selected, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.